BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37024473)

  • 1. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
    Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
    Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease.
    Pérez-Cañamás A; Benvegnù S; Rueda CB; Rábano A; Satrústegui J; Ledesma MD
    Mol Psychiatry; 2017 May; 22(5):711-723. PubMed ID: 27620840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurons regulate the esterification of bioactive lipid mediators in the brain of acid sphingomyelinase deficient mice.
    Taha AY; Gaudioso Á; Moran-Garrido M; Camunas-Alberca SM; Bachiller-Hernández J; Sáiz J; Ledesma MD; Barbas C
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110896. PubMed ID: 37956788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency.
    Gaudioso Á; Moreno-Huguet P; Casas J; Schuchman EH; Ledesma MD
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.
    Buccinnà B; Piccinini M; Prinetti A; Scandroglio F; Prioni S; Valsecchi M; Votta B; Grifoni S; Lupino E; Ramondetti C; Schuchman EH; Giordana MT; Sonnino S; Rinaudo MT
    J Neurochem; 2009 Apr; 109(1):105-15. PubMed ID: 19187445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease.
    Dodge JC; Clarke J; Treleaven CM; Taksir TV; Griffiths DA; Yang W; Fidler JA; Passini MA; Karey KP; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2009 Feb; 215(2):349-57. PubMed ID: 19059399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A.
    Carsana EV; Lunghi G; Prioni S; Mauri L; Loberto N; Prinetti A; Zucca FA; Bassi R; Sonnino S; Chiricozzi E; Duga S; Straniero L; Asselta R; Soldà G; Samarani M; Aureli M
    J Mol Neurosci; 2022 Jul; 72(7):1482-1499. PubMed ID: 35727525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A.
    Gabandé-Rodríguez E; Boya P; Labrador V; Dotti CG; Ledesma MD
    Cell Death Differ; 2014 Jun; 21(6):864-75. PubMed ID: 24488099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders.
    Gabandé-Rodríguez E; Pérez-Cañamás A; Soto-Huelin B; Mitroi DN; Sánchez-Redondo S; Martínez-Sáez E; Venero C; Peinado H; Ledesma MD
    EMBO J; 2019 Jan; 38(2):. PubMed ID: 30530526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type A.
    Long Y; Xu M; Li R; Dai S; Beers J; Chen G; Soheilian F; Baxa U; Wang M; Marugan JJ; Muro S; Li Z; Brady R; Zheng W
    Stem Cells Transl Med; 2016 Dec; 5(12):1644-1655. PubMed ID: 27484861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics.
    Murray JM; Thompson AM; Vitsky A; Hawes M; Chuang WL; Pacheco J; Wilson S; McPherson JM; Thurberg BL; Karey KP; Andrews L
    Mol Genet Metab; 2015 Feb; 114(2):217-25. PubMed ID: 25092414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration.
    Macauley SL; Sidman RL; Schuchman EH; Taksir T; Stewart GR
    Exp Neurol; 2008 Dec; 214(2):181-92. PubMed ID: 18778708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann-Pick A mouse.
    Yang WW; Dodge JC; Passini MA; Taksir TV; Griffiths D; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2007 Oct; 207(2):258-66. PubMed ID: 17686472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.
    Ledesma MD; Prinetti A; Sonnino S; Schuchman EH
    J Neurochem; 2011 Mar; 116(5):779-88. PubMed ID: 21214563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase.
    Galvan C; Camoletto PG; Cristofani F; Van Veldhoven PP; Ledesma MD
    Mol Biol Cell; 2008 Feb; 19(2):509-22. PubMed ID: 18032586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closure.
    Corcelle-Termeau E; Vindeløv SD; Hämälistö S; Mograbi B; Keldsbo A; Bräsen JH; Favaro E; Adam D; Szyniarowski P; Hofman P; Krautwald S; Farkas T; Petersen NH; Rohde M; Linkermann A; Jäättelä M
    Autophagy; 2016 May; 12(5):833-49. PubMed ID: 27070082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling.
    Bartoll A; Toledano-Zaragoza A; Casas J; Guzmán M; Schuchman EH; Ledesma MD
    EMBO Mol Med; 2020 Nov; 12(11):e11776. PubMed ID: 33016621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism.
    Breiden B; Sandhoff K
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMPD1 expression profile and mutation landscape help decipher genotype-phenotype association and precision diagnosis for acid sphingomyelinase deficiency.
    Wang R; Qin Z; Huang L; Luo H; Peng H; Zhou X; Zhao Z; Liu M; Yang P; Shi T
    Hereditas; 2023 Mar; 160(1):11. PubMed ID: 36907956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein D-mediated preservation of lysosomal function promotes cell survival and delays motor impairment in Niemann-Pick type A disease.
    Pascua-Maestro R; Corraliza-Gomez M; Fadrique-Rojo C; Ledesma MD; Schuchman EH; Sanchez D; Ganfornina MD
    Neurobiol Dis; 2020 Oct; 144():105046. PubMed ID: 32798728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.